For some years now, research has linked vitamin B3 to a lower risk of skin cancer. In a study published in 2015, for example, researchers from the University of Sydney in Australia found that nicotinamide, a form of vitamin B3, lowers the risk of non-melanoma skin cancers. Their research was conducted via a clinical trial involving 386 people aged between 30 and 91 years old, all of whom had had non-melanoma skin cancers two or more times during the previous five years. Patients who took 500 milligrams of nicotinamide twice a day were found to have a 23 percent lower risk of developing new cancers compared to those given placebo pills.
Studies carried out at the Dr. Rath Research Institute have shown that a specific combination of micronutrients is effective in combatting both melanoma and non-melanoma skin cancers. The combination tested includes vitamin C, the amino acids lysine and proline, and other micronutrients. Based on this groundbreaking approach, all of the key mechanisms that make cancer a deadly disease – including tumor growth, invasion and metastasis, angiogenesis (the formation of new blood vessels in tumors) and the immortality of cancer cells – can now be effectively and safely controlled.
To learn more about the natural control of skin cancer, see this article on our website.
Study Links Vitamin E And Carotenoids To Reduced Cognitive Decline
November 26, 2020Bill Gates Warns That Another Global Pandemic Is ‘Inevitable’
November 27, 2020Consuming More Vitamin B3 Can Protect Skin Cells From UV Exposure & Lower Cancer Risk
News
“Researchers in Italy say adding more niacin (vitamin B3) to your diet can protect the skin from ultraviolet (UV) exposure and reduce the risk of developing skin cancer.” [Source: studyfinds.org]
Comment
For some years now, research has linked vitamin B3 to a lower risk of skin cancer. In a study published in 2015, for example, researchers from the University of Sydney in Australia found that nicotinamide, a form of vitamin B3, lowers the risk of non-melanoma skin cancers. Their research was conducted via a clinical trial involving 386 people aged between 30 and 91 years old, all of whom had had non-melanoma skin cancers two or more times during the previous five years. Patients who took 500 milligrams of nicotinamide twice a day were found to have a 23 percent lower risk of developing new cancers compared to those given placebo pills.
Studies carried out at the Dr. Rath Research Institute have shown that a specific combination of micronutrients is effective in combatting both melanoma and non-melanoma skin cancers. The combination tested includes vitamin C, the amino acids lysine and proline, and other micronutrients. Based on this groundbreaking approach, all of the key mechanisms that make cancer a deadly disease – including tumor growth, invasion and metastasis, angiogenesis (the formation of new blood vessels in tumors) and the immortality of cancer cells – can now be effectively and safely controlled.
To learn more about the natural control of skin cancer, see this article on our website.
Dr. Rath Health Foundation
Related posts
Over 800 Million Adults Living With Diabetes, With More Than Half Not Receiving Treatment
Read more